| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/07/1996 | EP0695312A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
| 02/07/1996 | EP0695305A1 Method of forming oligonucleotides |
| 02/07/1996 | EP0695303A1 New pyridinium salts and their use for controlling helicobacter bacteria |
| 02/07/1996 | EP0695192A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 02/07/1996 | EP0695185A1 New method of treatment |
| 02/07/1996 | EP0671930A4 Prophylaxis and treatment of adverse oral conditions with biologically active peptides. |
| 02/07/1996 | EP0502049B1 Tumour necrosis factor antagonist |
| 02/07/1996 | CN1116427A Polypeptide and anti-hiv agent prepared therefrom |
| 02/07/1996 | CN1116406A Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/07/1996 | CN1116204A Processes for the diastereoselective synthesis of nucleosides |
| 02/07/1996 | CN1030917C Process for preparing heterocyclic derivatives |
| 02/07/1996 | CN1030916C Process for preparing hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
| 02/06/1996 | US5489697 Catalytic condensation of ethylbutyryl acetate and phloroglucinol yields 5,7-dihydroxy-4-propylcoumarin which is acetylated at position 8, then reacted with 4,4-dimethoxy-2-methylbutan-2-ol, then treated with acetal and reduced |
| 02/06/1996 | US5489600 Anticholesterol and -lipemic agents; arteriosclerosis; enzyme inhibiors |
| 02/06/1996 | US5489586 Method for treating inflammatory disease in humans |
| 02/06/1996 | US5489585 Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections |
| 02/06/1996 | US5489575 Polypeptides and their use |
| 02/05/1996 | CA2155153A1 Quinolone- and naphthyridonecarboxylic acid derivatives |
| 02/04/1996 | CA2155170A1 Stably storable and readily water soluble composition of cephalosporin for injections |
| 02/04/1996 | CA2155092A1 Benzoxazolyl- and benzothiazolyloxazolidinones |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002649A1 Modified plant viruses as vectors of heterologous peptides |
| 02/01/1996 | WO1996002648A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002557A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002554A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | WO1996002550A1 7-o-carbamoyl heptose derivatives, process for their production and their use and screening process for their detection |
| 02/01/1996 | WO1996002544A1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 02/01/1996 | WO1996002512A1 Trifluoromethylquinolinecarboxylic acid derivative |
| 02/01/1996 | WO1996002505A1 Thiopyridyl compounds for controlling helicobacter bacteria |
| 02/01/1996 | WO1996002499A1 Difluorostatone antiviral agents |
| 02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | WO1996002271A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
| 02/01/1996 | WO1996002229A2 Soap composition |
| 02/01/1996 | WO1995035112A3 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 02/01/1996 | DE19526163A1 New ganciclovir mono:esters and intermediates |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195444A1 Thiopyridyl compounds for controlling helicobacter bacteria |
| 02/01/1996 | CA2195091A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | CA2195082A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | CA2194435A1 Trifluoromethylquinolinecarboxylic acid derivative |
| 02/01/1996 | CA2194398A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 01/31/1996 | EP0694562A1 Preparation of alpha-1-antichymotrypsin |
| 01/31/1996 | EP0694560A2 Production of antigens of Pasteurella |
| 01/31/1996 | EP0694559A2 2',5'-Phosphorothioate oligoadenylates and antiviral uses thereof |
| 01/31/1996 | EP0694547A2 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 01/31/1996 | EP0694544A1 Benzofuranyl- and benzothienyloxazolidinones |
| 01/31/1996 | EP0694543A1 6-membered N-heteroaryloxazolidinones |
| 01/31/1996 | EP0694309A2 Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection |
| 01/31/1996 | EP0694306A1 Antiviral powder, antiviral extract, and pharmaceutical preparation containing said powder and/or said extract |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0693938A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 01/31/1996 | EP0693937A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 01/31/1996 | EP0693934A1 Methods and compositions for the prevention or treatment of sexually transmitted diseases |
| 01/31/1996 | EP0693925A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | EP0538352B1 IMMUNOGENIC PEPTIDE SEQUENCE FROM $i(ECHINOCOCCUS GRANULOSUS), DNA SEQUENCE CODING FOR SAID PEPTIDE SEQUENCE, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 01/30/1996 | US5488051 Bactericides, fungicides, algicides and antiprotozoa agents |
| 01/30/1996 | US5488034 Pharmaceutical composition comprising BPI proteins |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001833A1 Therapeutic compounds |
| 01/25/1996 | WO1996001825A1 Heterobicyclic derivatives |
| 01/25/1996 | WO1996001822A1 Anti-helicobacter acyl derivatives of azolones |
| 01/25/1996 | WO1996001821A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 01/25/1996 | WO1996001820A1 Anti-helicobacter urea and thiourea derivatives of azolones |
| 01/25/1996 | WO1996001818A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 01/25/1996 | WO1996001614A2 Rna component of telomerase |
| 01/25/1996 | CA2194872A1 Pyridopyrazine derivatives |
| 01/25/1996 | CA2194565A1 Anti-helicobacter urea and thiourea derivatives of azolones |
| 01/25/1996 | CA2194563A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 01/25/1996 | CA2194562A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 01/25/1996 | CA2193490A1 Anti-helicobacter acyl derivatives of azolones |
| 01/24/1996 | EP0693551A1 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/24/1996 | EP0693498A1 Antiviral compounds |
| 01/24/1996 | EP0693496A1 Novel cephalosporins having a substituted benzyloxyimino radical in position 7, process for their preparation and their use as medicaments |
| 01/24/1996 | EP0693491A1 Oxazolidinones substituted by 5-membered heteroaryl group as antibacterial medicine |
| 01/24/1996 | EP0693130A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 01/24/1996 | EP0693126A1 Method for selective inactivation of viral replication |
| 01/24/1996 | EP0693123A1 Modified oligonucleotides having improved anti-influenza activity |
| 01/24/1996 | EP0693077A1 Antiviral compounds |
| 01/24/1996 | EP0693071A1 New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use |
| 01/24/1996 | EP0692974A1 Multicomponent clostridial vaccines using saponin adjuvants |
| 01/24/1996 | EP0692963A1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 01/24/1996 | EP0692930A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 01/24/1996 | EP0500686B1 Tricyclic [6,5,5]/[6,6,5]-fused oxazolidinone antibacterial agents |
| 01/24/1996 | CN1115320A Nucleosides and oligonucleotides having 2'-ether groups |
| 01/24/1996 | CN1030767C Method for preparing of 1-methylcarbapenem derivatives |
| 01/23/1996 | US5486630 Legionella specific antibiotic |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486520 1,3-oxathiolanes useful in the treatment of hepatitis |
| 01/23/1996 | US5486510 Method and compositions for modulating or control of immune responses in humans |
| 01/23/1996 | US5486466 Enzyme inhibitors |
| 01/23/1996 | CA1337988C Azole derivative and azole mycocide |
| 01/23/1996 | CA1337985C 4-substituted anthracyclinones and their preparation |
| 01/23/1996 | CA1337978C Antibiotic a 42867 and the addition salts thereof |
| 01/21/1996 | CA2154026A1 5-membered heteroaryl-oxazolidinones |